Drugs / ReGen-GF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05932732 | Nov 2023 → Oct 2024 | cutis laxa | Austin Institute for Clinical Research | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ReGen-GF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05932732 ↗ |